
Jan 8, 2025, 12:00
Yakup Ergün: NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:
“NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing
Pleural effusion cfDNA NGS achieved an 88% mutation detection rate, outperforming cell pellet Sanger sequencing (78%) and clinical tissue testing (66%).”
Authors: Hsin-Yi Wang et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 18:13
Mar 29, 2025, 18:03
Mar 29, 2025, 18:02
Mar 29, 2025, 17:57
Mar 29, 2025, 17:40
Mar 29, 2025, 17:30
Mar 29, 2025, 17:14